RO6870810/TEN-010

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO6870810/TEN-010, covering 2017-12-11 to 2017-12-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RO6870810/TEN-010 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndrome [Phase 1]